News
HIND
1.580
-3.07%
-0.050
Weekly Report: what happened at HIND last week (1102-1106)?
Weekly Report · 5d ago
Weekly Report: what happened at HIND last week (1026-1030)?
Weekly Report · 11/02 09:47
Weekly Report: what happened at HIND last week (1019-1023)?
Weekly Report · 10/26 09:47
Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School
Barchart · 10/26 07:00
Weekly Report: what happened at HIND last week (1012-1016)?
Weekly Report · 10/19 09:47
Weekly Report: what happened at HIND last week (1005-1009)?
Weekly Report · 10/12 09:50
Vyome receives USPTO Notice of Allowance for U.S. patent covering VT-1908
TipRanks · 10/05 12:16
Weekly Report: what happened at HIND last week (0928-1002)?
Weekly Report · 10/05 09:50
Weekly Report: what happened at HIND last week (0921-0925)?
Weekly Report · 09/28 09:47
Weekly Report: what happened at HIND last week (0914-0918)?
Weekly Report · 09/21 09:47
Vyome Holdings' ReShape Lifesciences Has Received A Notice Of Allowance For A U.S. Patent Titled "VAGUS NERVE NEUROMODULATION FOR THE TREATMENT OF THE HYPOGLYCEMIC STATE".
Benzinga · 09/18 19:58
Vyome appoints new CFO
Seeking Alpha · 09/14 12:12
Vyome appoints Leonard as Chief Financial Officer
TipRanks · 09/14 12:11
Vyome Holdings Appoints Jerry Leonard As CFO, Succeeding Robert Dickey IV, Who Served As Interim CFO Since August 2025
Benzinga · 09/14 12:06
*Vyome Holdings: Leonard Succeeds Interim CFO Robert Dickey >HIND
Dow Jones · 09/14 12:01
*Vyome Holdings: Leonard Assumed the Role From Sept 1 >HIND
Dow Jones · 09/14 12:01
*Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard As Chief Financial Officer >HIND
Dow Jones · 09/14 12:00
*Vyome Holdings Names Jerry Leonard CFO >HIND
Dow Jones · 09/14 12:00
Weekly Report: what happened at HIND last week (0907-0911)?
Weekly Report · 09/14 09:50
Weekly Report: what happened at HIND last week (0831-0904)?
Weekly Report · 09/07 09:46
More
Webull provides a variety of real-time HIND stock news. You can receive the latest news about Vyome Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About HIND
Vyome Holdings, Inc. is a clinical-stage healthcare holding company. The Company is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.